Frontier Capital Management CO LLC Pacira Bio Sciences, Inc. Transaction History

Frontier Capital Management CO LLC

  • $9.96 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$25.5 - $31.51 $1.98 Million - $2.44 Million
-77,470 Reduced 4.05%
1,836,873 $52.6 Million
Q1 2024

May 15, 2024
SELL
$27.7 - $35.48 $4.71 Million - $6.04 Million
-170,199 Reduced 8.16%
1,914,343 $55.9 Million
Q4 2023

Feb 14, 2024
BUY
$26.32 - $34.31 $7.5 Million - $9.78 Million
285,045 Added 15.84%
2,084,542 $70.3 Million
Q3 2023

Nov 14, 2023
BUY
$30.68 - $40.09 $3.5 Million - $4.58 Million
114,242 Added 6.78%
1,799,497 $55.2 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $47.5 $2.93 Million - $3.86 Million
81,171 Added 5.06%
1,685,255 $67.5 Million
Q1 2023

May 15, 2023
BUY
$35.53 - $43.38 $19.3 Million - $23.5 Million
542,661 Added 51.13%
1,604,084 $65.5 Million
Q4 2022

Feb 14, 2023
SELL
$38.19 - $57.45 $2.81 Million - $4.23 Million
-73,564 Reduced 6.48%
1,061,423 $41 Million
Q3 2022

Nov 14, 2022
BUY
$51.24 - $58.89 $3.71 Million - $4.26 Million
72,320 Added 6.81%
1,134,987 $60.4 Million
Q2 2022

Jul 20, 2022
BUY
$51.49 - $81.64 $409,088 - $648,629
7,945 Added 0.75%
1,062,667 $62 Million
Q1 2022

Apr 14, 2022
BUY
$60.03 - $76.49 $7.49 Million - $9.55 Million
124,851 Added 13.43%
1,054,722 $80.5 Million
Q4 2021

Jan 19, 2022
BUY
$47.97 - $62.21 $6.52 Million - $8.46 Million
135,927 Added 17.12%
929,871 $56 Million
Q3 2021

Oct 19, 2021
SELL
$54.64 - $61.3 $990,568 - $1.11 Million
-18,129 Reduced 2.23%
793,944 $44.5 Million
Q2 2021

Aug 09, 2021
SELL
$59.18 - $69.99 $13.4 Million - $15.8 Million
-226,302 Reduced 21.79%
812,073 $49.3 Million
Q1 2021

May 13, 2021
BUY
$59.31 - $78.82 $366,417 - $486,949
6,178 Added 0.6%
1,038,375 $72.8 Million
Q4 2020

Jan 19, 2021
SELL
$50.47 - $66.26 $2.62 Million - $3.44 Million
-51,901 Reduced 4.79%
1,032,197 $61.8 Million
Q3 2020

Nov 16, 2020
SELL
$51.97 - $63.0 $1.07 Million - $1.3 Million
-20,593 Reduced 1.86%
1,084,098 $65.2 Million
Q2 2020

Jul 17, 2020
BUY
$30.8 - $52.47 $770,585 - $1.31 Million
25,019 Added 2.32%
1,104,691 $58 Million
Q1 2020

Apr 16, 2020
SELL
$28.4 - $50.7 $7.67 Million - $13.7 Million
-269,977 Reduced 20.0%
1,079,672 $36.2 Million
Q4 2019

Feb 14, 2020
SELL
$36.31 - $46.83 $11.9 Million - $15.4 Million
-328,835 Reduced 19.59%
1,349,649 $61.1 Million
Q3 2019

Nov 14, 2019
BUY
$35.66 - $44.99 $2.27 Million - $2.86 Million
63,613 Added 3.94%
1,678,484 $63.9 Million
Q2 2019

Aug 14, 2019
BUY
$36.57 - $47.97 $8.6 Million - $11.3 Million
235,246 Added 17.05%
1,614,871 $70.2 Million
Q1 2019

May 07, 2019
BUY
$36.47 - $42.17 $50.3 Million - $58.2 Million
1,379,625 New
1,379,625 $52.5 Million

Others Institutions Holding PCRX

# of Institutions
263
Shares Held
50.4M
Call Options Held
429K
Put Options Held
391K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email